|
|
Pharmacological Management of Dementia: Current Approaches and Emerging Therapies
Recorded for 2025 Fall Conference
|
|
Facebook
LinkedIn
E-Mail
|
(1211)
|
Activity Duration| Content Expires: | February 28, 2027 (11:55 p.m. CT)
CE for this activity will not be available after this date. |
This CE activity was recorded for the 2025 AANP Fall Conference.  | This activity includes closed captioning. |
| Delivery Note: The content for this activity was previously presented during the virtual 2025 AANP Fall Conference. If you already completed the content of this activity while attending the virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies. |
Overview
This session provides nurse practitioners with a comprehensive overview of evidence-based pharmacological interventions for managing Alzheimer's disease and related dementias. The presentation will primarily focus on established treatment modalities for cognitive symptoms and functional decline. Attendees will learn practical approaches to managing common neuropsychiatric symptoms of dementia, from anxiety and depression to disordered sleep, agitation, and psychosis, with special consideration of risk-benefit analyses for various medication classes. The session will address important considerations for geriatric pharmacology. We will also discuss appropriate use of emerging therapies in the Alzheimer's treatment landscape, including disease-modifying treatments. Participants will gain practical knowledge to optimize referrals to subspecialist care and treatment, along with guidance for medication management for patients with dementia, focusing on appropriate drug selection, symptom target identification, and monitoring for therapeutic outcomes and adverse effects.
Objectives
- Describe common symptoms of dementia and associated neurotransmitter perversions due to Alzheimer's disease and related disorders.
- Apply a structured and targeted approach to prescribing treatments for neuropsychiatric symptoms of dementia.
- Identify appropriate patients at the appropriate time for disease-modifying treatments in Alzheimer's disease.
Speaker
Carolyn K Clevenger, DNP, GNP-BC, AGPCNP-BC, FAANP, FGSA, FAAN
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.
The speaker has the following disclosures:- I am a clinical advisor to Otsuka, Novo Nordisk, Eli Lilly, Axsome, BrainCheck on Alzheimer’s disease.
All relevant financial relationships have been mitigated.
DisclaimerIndividuals who have contributed to the CE Center (content originally from the 2025 AANP Fall Conference) were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete all educational content:
- OnDemand Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
- After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button. At the top of the certificate screen, use the provided dropdown menu and select AANP Certificate of Completion.
- A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- A copy of the certificate will be automatically added to your AANP CE Tracker.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1.12 Contact Hour(s) of CE,
0.95 of which may be applied towards Pharmacology
|
|
Additional CE activities of interest
(OnDemand)
MODULE 6: Opioid Prescribing Update
(OnDemand)
Acute Kidney Injury and Chronic Kidney Disease: Guideline Updates
(OnDemand)
Managing Insomnia
(OnDemand)
MODULE 3: Non-Opioid Pharmacology Treatment of Pain
(OnDemand)
Migraine, Diagnosis and Treatment Tried, True and New
(OnDemand)
MODULE 7: Buprenorphine and Methadone
(OnDemand)
MODULE 8: Special Populations and Opioid Use Disorder Treatment
(OnDemand)
Beyond Medications: Non-Pharmacologic Strategies for Acute & Chronic Disease Management
(OnDemand)
Autoimmune Diseases in Dermatology: Diagnosis, Management, and Clinical Pearls
(OnDemand)
MODULE 5: Substance Use Disorders - Opioids
(OnDemand)
MODULE 1: Pathophysiology of Pain and Neurobiology of Addiction Overview
(OnDemand)
MODULE 2: Non-Pharmacologic Treatment of Pain
|
|
Adding Registration, Please wait...
